Application dates: 01 August 2017 to 21 November 2017
The Public Health Research Programme are accepting full evidence synthesis applications to their researcher-led workstream:
17/91 - evidence synthesis
In order to apply you will need to carefully review the:
The closing dates for applications is 1pm, 21 November 2017.
*Please note: This document is to be used as a guide and to assist with completion of the on-line application form only, for example to see how many characters are accepted in each section and how the printed complete form is laid out. Please do not try to use this as an application form, you must apply using the online form available through the links available when calls are open. You should also refer to the application form guidance notes which can be found next to the ‘Apply Now’ button.
All primary research projects are expected to establish a programme appointed Study/Trial Steering Committee and it is important that you read the TSC/SSC Guidance before completing your application. Costs incurred by this committee should be included in the budget as appropriate.
Applications received by 1pm on the 21 November 2017, and deemed within remit, will be assessed for their importance to public health by the Programme Advisory Board (PAB) in January 2018.
Shortlisted applications from this round will be considered by the Research Funding Board (RFB) in February 2018, and assessed for scientific quality, feasibility and value for money. Applicants will be informed of the RFB's decisions in March 2018.
Please note: If a very high response is received, some applications may not be taken forward for further assessment if they are deemed to be non-competitive and/or it may be necessary to defer some applications until a later date. 'Non-Competitive' means that an application is not of a sufficiently high standard to be taken forward for further assessment in comparison with other applications received and funded by the PHR Programme because it has little or no realistic prospect of funding. This may be because of scientific quality, cost, scale/duration, or the makeup of the project team.